| Detected | Trial | Change |
|---|---|---|
| 2026-05-20 | NCT07404865 Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease |
Trial sites expanded: 18 -> 24 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07643038 Treatment Strategy for Patients With RA-ILD | Phase 4 | Not Yet Recruiting |
| 2026-05-19 | NCT07597733 Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy | Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07643038 | Treatment Strategy for Patients With RA-ILD | Rheumatoid Arthritis Associated Interstitial Lung Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT07249632 | A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) | Myasthenia Gravis, Ocular | Recruiting |
| NCT06456580 | A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) | Generalized Myasthenia Gravis | Recruiting |
| NCT07404865 | Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease | Primary Sjogren's Disease | Recruiting |
| NCT07495033 | Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With… | CTD-ILD | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07355257 | TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) | Inflammatory Myopathy | Not Yet Recruiting |
| Phase 2 | |||
| NCT07340463 | The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in… | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT07522099 | Chinese Adults With Kidney Disease | Immunoglobulin A Nephropathy (IgAN) | Recruiting |
| Not specified | |||
| NCT07298928 | A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular… | Effectiveness | Not Yet Recruiting |
| NCT07597733 | Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy | Refractory Chronic Inflammatory Demyelinating Polyneuropathy | Active, Not Recruiting |